BRCA2 and breast cancer: Considering BRCA2 PV carriers, the strongest association with ED was observed for the ER- BC PRS (OR = 2.27; 95% CI: 1.45–3.78, p<0.001), whereas the overall and ER+ BC PRS did not show statistically significant association with ED (Table 2).